With respect to the effect of aspirin on cancer cell stemness properties, we found that the immunocytochemical staining of SOX2 and OCT4 stemness markers decreases in the aspirin-treated groups versus DMSO controls (Fig. 2h, i). This evidence concerns the gene POU5F1 and cancer.